The potential effectiveness of topical dutasteride, as well as other hairloss treatments such as finasteride, RU58841, minoxidil, and various vitamins. Experiences from users who have used these treatments were shared.
Kintor's GT20029, a treatment for hairloss, has completed Phase 1 successfully, showing promise as an androgen receptor degrader that could potentially regrow hair. It is considered more effective than Pyrilutamide, with infrequent dosing and minimal systemic absorption.
The post and conversation are about the role of the enzyme 3alpha-hydroxysteroid reductase in hairloss and the potential of compounds like procyanidin B2 and sulforaphane to boost its activity for hair regrowth. Further research is needed to develop effective treatments based on this theory.
The conversation discusses anticipation for CB-03-01, a potential new hairloss treatment that may be more effective and have a cleaner safety profile than finasteride. Users are hopeful but cautious, discussing current treatments like minoxidil, nizoral, and dermarolling, and the possibility of combining them with CB-03-01 for better results.
Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
A 19-year-old is distressed about his 17-year-old autistic brother's hairloss, projecting his own insecurities despite being on finasteride and dutasteride. Replies suggest the brother might not care about balding, and the poster should address his own issues.
A 28-year-old man saw hair regrowth after 1.5 years using a topical treatment combining 0.3% finasteride and 6% minoxidil. He initially experienced anxiety with oral finasteride but had no side effects with the topical version.